...
| WMDA Standard | Title and link to document | Explanation | Status |
|---|---|---|---|
3.13 4.09 | Unrelated hematopoietic stem cell donors as research subjects Bone Marrow Transplantation (2011), 46: 10-13 | Discuss various implications of research participation of unrelated stem cell donors in research protocols. | Current (2017) |
| 10.13 | Donor and liability of donor registries, donor centres and collection centres-recommendations Bone Marrow Transplantation (2004), 33: 467-470 | The paper outlines the ethical aspects of liability of involved parties and the need for insurance coverage. The article has shortcoming with the respect to legal advices. | Under review (2017), for more details: |
| GRID | |||
2.11 2.11.1 | WMDA Quality Manual | ||
| Related donors | Family donor care management: principles and recommendations Bone Marrow Transplantation (2010) 45: 1269-1273 | This document hopes to encourage increased collaboration between those caring for related and unrelated donors, and build on the extensive work, which has already been undertaken in this field to homogenize care. | Current (2017) |
Recruitment of volunteer donors
| WMDA Standard | Title and link to document | Explanation | Status |
|---|---|---|---|
3.22 3.22.2 | Guidance for assessing the medical suitability for adult volunteer donors | The guidance below reflects the consensus opinion provided by the WMDA donor medical suitability committee. The purpose of this guidance is to provide globally harmonised medical assessment criteria which simultaneously protect the interest of donors whilst ensuring the safety of cellular products across international boundaries. | Current (2017) |
| 3.02 | Bone Marrow Transplantation (2013) 48: 1480150 | Paper providing recommendations regarding qualifications and training of recruiters | |
| Key Performance Indicators for Registries | |||
| 3.03, 3.04, 3.09, 6.07, 6.07.1, 3.24, 10.11, 10.13 | Bone Marrow Transplantation (2010) 45: 832-838 | This paper is providing information about the donor care standards of the WMDA. The paper has been published in 2010, the wording of the WMDA Standards might have changed over time. | Current (2017) |
Donor search request
| WMDA Standard | Title and link to document | Explanation | Status |
|---|---|---|---|
Recommendation on the training of staff performing patient donor search and HLA matching activities | |||
| Suggested procedures for international unrelated search | |||
| 7.01 | WMDA Guidelines for subsequent donations following initial BM or PBSCs Bone Marrow Transplantation (2011) 46: 1409-1412 | This guideline is intended to outline where subsequent donations would routinely be considered appropriate (from the donor's point-of-view), as well as the frequency and timing of such donations. | Under review, see https://share.wmda.info/x/8qWbEw for more information |
| 3.03, 3.06, 6.06 | Donor commitment and patient needs Bone Marrow Transplantation (2004) 33: 225-230 | This paper describes ethical issues related to the donation of hematopoietic stem cell products with respect to recruitment, evaluation, workup, and follow-up of unrelated donors. | Current (2017) |
...
| WMDA Standard | Title and link to document | Explanation | Status |
|---|---|---|---|
8.05 | WMDA recommendation on the use of biosimilar filgrastims | Current (2018) | |
| 3.03 | Blood (2010) 117: 21-25 | This paper describes the reasons that the WMDA continues to believe that HSC donors should not be paid due to ethical concerns raised by remuneration, potential to damage the public will to act altruistically, the potential for coercion and exploitation of donors, increased risk to patients, harm to local transplantation programs and international stem cell exchange, and the possibility of benefiting some patients while disadvantaging others. | Current (2017) |
| 1.08 | Bone Marrow Transplantation (2018) | This paper describes the general requirements and recommendations for collaboration with the collection and apheresis centers and define critical procedures for the collection of the stem cell product, such as information session, medical assessment, product collection, quality controls, product handover for transportation, and donor follow-up. The specific guidelines are accompanied by detailed checklists and forms that can be found in Supplementary Information and may be used during an initial or follow-up on-site or paper-based audit. For more information you can visit: https://share.wmda.info/x/OAKQEQ | Current (2018) |
| Labeling |
Post-donation
| WMDA Standard | Title and link to document | Explanation | Status |
|---|---|---|---|
Towards a global system | |||
...
| WMDA Standard | Title and link to document | Explanation | Status |
|---|---|---|---|
2.11.2 | World marrow donor association crisis response, business continuity, and disaster recovery guidelines. | Current (2017) | |
Finance and administration
...